Jun 28, 2019
Chronic Lower Back Pain Chronic lower back pain (CLBP) is defined as pain that persists for 12 weeks or longer, even after an initial injury or the underlying cause of acute low back pain has been treated. Low back pain is very common and at one point everyone may have faced this problem. According to DelveIn...
Read More...
Jun 28, 2019
Myasthenia Gravis June is Myasthenia Gravis Awareness Month. Myasthenia gravis is a disorder causing weakness and easy fatigue of voluntary muscles. It is caused by a breakdown in the communication between nerves and muscles, usually because of an immunological problem.
Read More...
Jun 27, 2019
Sanifit raises USD 80.9 M to advance Calciphylaxis Pipeline Sanifit, a clinical-stage biopharmaceutical company, has raised USD 80.9 million ( €72.2 million ) in total private fundraising. The financing mainly consisted led by Spain’s Caixa Capital Risc, along with many new investors, including Columbus Venture ...
Read More...
Jun 26, 2019
Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy treatment or a psychological treatment method, developed by American clinical psychologist, Dr Francine Shapiro, in the 1980s. The therapy is a popular way of treatment used to recover from distressing and disturbing life experiences that resul...
Read More...
Jun 27, 2019
Post-Traumatic Stress Disorder Awareness Day, a day dedicated to increasing awareness regarding PTSD (Post Traumatic Stress Disorder). It is celebrated annually on 27 June. Post-Traumatic Stress Disorder (PTSD) is a seriously debilitating condition that can develop in a person who has experienced or witnessed a...
Read More...
Jun 25, 2019
FDA grants priority review to Zejula Niraparib (Zejula) received a priority review by the U.S. FDA, in response to a supplemental New Drug Application (sNDA) submitted by Tesaro. The drug, acquired by GlaxoSmithKline along with the drugmaker Tesaro for USD 5.1 Million, has an action date of October 24, 2019. T...
Read More...
Sep 30, 2024
Pompe disease is an inherited rare disease, often fatal, with the potential to damage the heart, liver, and skeletal muscles. Absence of an essential protein, Due to the mutation in a gene encoding GAA, there is an absence of a critical protein leading to a complex buildup of sugar, hence, damaging the heart, liver...
Read More...
Sep 30, 2024
The treatment landscape for Pompe disease is undergoing a remarkable shift, especially within emerging markets, as increased awareness, regulatory advancements, and broader access to cutting-edge therapies begin to reshape the future for patients. Pompe disease is a rare and inherited genetic disorder caused by a d...
Read More...
Jun 20, 2019
Gilead jumps into a competitive Protein degradation field, signs a USD 45 M Nurix deal Gilead Sciences is turning to Nurix Therapeutics for enhancing cancer pipeline. Gilead is ready to pay USD 45 million upfront, and if all the targets are achieved the deal could reach up to USD 2.3 billion. Nurix is a drug de...
Read More...
Jun 24, 2019
Cataract A cataract is a clouding of the lens in the eye that affects vision. Most cataracts are related to ageing. Cataracts are very common in older people. A cataract can occur in either or both eyes. It cannot spread from one eye to the other. June is the month of Cataract Awareness Month, and the sole a...
Read More...